Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Matell

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
European Neurology|January 1, 1975
Drainage of thoracic duct lymph in twelve patients with myasthenia gravisK Bergström, C Franksson, G Matell, et al.
Tissue Antigens|August 1, 1978
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravisJ Säfwenberg, L Hammarström, J B Lindblom, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Effects of some immunosuppressive procedures on myasthenia gravisG Matell, K Bergström, C Franksson, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Neuromuscular safety margin: genetical, immunological and electrophysiological determinants in relatives of myasthenic patients: a preliminary reportR Pirkanen, K Bergström, L Hammarström, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibodyR Ahlberg, Q Yi, R Pirskanen, et al.
Neurology|September 1, 1994
Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivityR Ahlberg, Q Yi, R Pirskanen, et al.
Lakartidningen|April 19, 1989
[Adverse effects of drugs and computerized registries--a threat or a possibility?]U Bergman, R Linnarsson, G Boethius, et al.
The New England Journal of Medicine|December 22, 1983
Myasthenia gravis after bone-marrow transplantation. Evidence for a donor originC I Smith, J A Aarli, P Biberfeld, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
European Neurology|January 1, 1975
Drainage of thoracic duct lymph in twelve patients with myasthenia gravisK Bergström, C Franksson, G Matell, et al.
Tissue Antigens|August 1, 1978
HLA-A, -B, -C and -D antigens in male patients with myasthenia gravisJ Säfwenberg, L Hammarström, J B Lindblom, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Effects of some immunosuppressive procedures on myasthenia gravisG Matell, K Bergström, C Franksson, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Neuromuscular safety margin: genetical, immunological and electrophysiological determinants in relatives of myasthenic patients: a preliminary reportR Pirkanen, K Bergström, L Hammarström, et al.
Annals of the New York Academy of Sciences|June 21, 1993
Clinical improvement of myasthenia gravis by treatment with a chimeric anti-CD4 monoclonal antibodyR Ahlberg, Q Yi, R Pirskanen, et al.
Neurology|September 1, 1994
Treatment of myasthenia gravis with anti-CD4 antibody: improvement correlates to decreased T-cell autoreactivityR Ahlberg, Q Yi, R Pirskanen, et al.
Lakartidningen|April 19, 1989
[Adverse effects of drugs and computerized registries--a threat or a possibility?]U Bergman, R Linnarsson, G Boethius, et al.
The New England Journal of Medicine|December 22, 1983
Myasthenia gravis after bone-marrow transplantation. Evidence for a donor originC I Smith, J A Aarli, P Biberfeld, et al.
Pageof 6